We are live on ! Find out more
NCCM

Nine Chapters Capital Management Portfolio holdings

AUM $45.4M
1-Year Est. Return 14.43%
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
+14.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$578M
AUM Growth
–
Cap. Flow
+$593M
Cap. Flow %
102.57%
Top 10 Hldgs %
11.3%
Holding
613
New
612
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$10.7M
2
TRV icon
Travelers Companies
TRV
+$7.59M
3
CAG icon
Conagra Brands
CAG
+$7.39M
4
QCOM icon
Qualcomm
QCOM
+$6.66M
5
VLO icon
Valero Energy
VLO
+$6.61M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 15.04%
2 Consumer Discretionary 12.94%
3 Industrials 12.34%
4 Technology 10.66%
5 Energy 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGNX
601
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$74K 0.01%
+16,700
New +$74.9K
WRES
602
DELISTED
WARREN RESOURCES INC
WRES
$61K 0.01%
+23,800
New +$66.8K
LSCC icon
603
Lattice Semiconductor
LSCC
$18B
$56K 0.01%
+11,000
New +$55.3K
RXII
604
DELISTED
GALENA BIOPHARMA INC COM
RXII
$53K 0.01%
+23,900
New +$53K
ARQL
605
DELISTED
Arqule Inc
ARQL
$42K 0.01%
+18,200
New +$49.1K
ASTX
606
DELISTED
ASTEX PHARMACEUTICALS, INC COM
ASTX
$42K 0.01%
+10,300
New +$55.4K
HZNP
607
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$34K 0.01%
+13,700
New +$32.9K
MBOT icon
608
Microbot Medical
MBOT
$123M
$33K 0.01%
+12
New +$33.8K
DVAX
609
DELISTED
Dynavax Technologies
DVAX
$30K 0.01%
+2,710
New +$57.1K
CDMO
610
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$30K 0.01%
+3,329
New +$34.9K
BTM
611
DELISTED
OI S.A. SPON ADR REPSTG 3 PFD SHS (BRA)
BTM
$24K ﹤0.01%
+13,100
New +$24K
CTIC
612
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$18K ﹤0.01%
+1,730
New +$20.3K
FCEL icon
613
FuelCell Energy
FCEL
$1.72B
$14K ﹤0.01%
+2
New +$9.89K
21 22 23 24
25

Similar funds

CZPM
Capital Z Partners Management New York $47.4M AUM 35.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
DAC
Dymon Asia Capital Singapore $48.4M AUM 73.84% 1-Year Est. Return
TCM
Trishield Capital Management New York $40.3M AUM
SAC
SPQ Asia Capital Hong Kong $37.7M AUM 121.14% 1-Year Est. Return
PCP
Proprium Capital Partners Stamford, Connecticut $54M AUM 7.85% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
A
Aetna Hartford, Connecticut $35.3M AUM 7.55% 1-Year Est. Return

Nine Chapters Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Nine Chapters Capital Management, which disclosed 613 positions worth $578M. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 195,900 shares worth $9.62M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, followed by Consumer Discretionary and Industrials.

  • Nine Chapters Capital Management's largest Q2 2013 buy was Eli Lilly: 195,900 shares worth $9.62M.
  • Nine Chapters Capital Management's ten largest holdings make up 11% of its $578M portfolio in Q2 2013.
  • Nine Chapters Capital Management disclosed 613 positions in Q2 2013, its first 13F filing on record.

Based on Nine Chapters Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.